Cafepharma Today

May 19 2025 - Regeneron wins bid to buy 23andMe out of bankruptcy
Regeneron wins bid to buy 23andMe out of bankruptcy
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Japan follows UK in GSK's comeback tour for Blenrep
FDA clears Novavax’s COVID-19 vaccine with usage restrictions
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline: Why Is This Pharmaceutical Giant Stepping Out Of The Cancer Arena?
Seeking Alpha
Friday, May 9, 2014 - 8:11am
tags:
GSK, cancer, Novartis
J&J /Gilead HCV Combo Drug Filed
Yahoo/Zacks.com
Thursday, May 8, 2014 - 5:20pm
tags:
JNJ, Gilead Sciences, hepatitis C, Olysio, Sovaldi
FDA approves Zontivity to lower heart attack, stroke risk in high-risk patients
The Fly on the Wall
Thursday, May 8, 2014 - 5:06pm
tags:
stroke, heart attakc, Zontivity, Merck, FDA
Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave
Fierce Pharma Marketing
Thursday, May 8, 2014 - 12:30pm
tags:
oncology, JNJ, Roche, Celgene, Zytiga, Kadcyla, Nexavar, Gleevec
Sarepta's Loss Widens 59% as it Prepares Eteplirsen For a New Drug Application Filing
Motley Fool
Thursday, May 8, 2014 - 12:26pm
tags:
Sarepta Therapeutics, earnings
Regeneron's Profit Soared 31% on Higher Collaboration Revenue and Eylea Sales
Motley Fool
Thursday, May 8, 2014 - 12:25pm
tags:
Regeneron, earnings
GTx says current POWER trials data insufficient to support filing NDA
The Fly on the Wall
Thursday, May 8, 2014 - 11:23am
tags:
GTx, enobosarm, non-small cell lung cancer
Dendreon 1Q Earnings a Mixed Bag
Motley Fool
Thursday, May 8, 2014 - 11:20am
tags:
earnings, Dendreon
Sun Pharma Recalls 400,000 Bottles of Drugs in U.S., FDA Says
Bloomberg
Thursday, May 8, 2014 - 11:19am
tags:
Sun Pharma, recalls, FDA, India
Merck, AiCuris announce publication of letermovir Phase 2 trial results
The Fly on the Wall
Thursday, May 8, 2014 - 11:18am
tags:
AiCuris, Merck, letermovir, CMV
EU likely to block any UK intervention in AstraZeneca bid: lawyers
Yahoo/Reuters
Thursday, May 8, 2014 - 10:55am
tags:
Europe, UK, AstraZeneca, M&A, Pfizer
AstraZeneca starts late-stage study of key new cancer drug
Yahoo/Reuters
Thursday, May 8, 2014 - 10:54am
tags:
AstraZeneca, anti-PD-L1, MEDI4736, non-small cell lung cancer
Pfizer Raising AstraZeneca Bid Means More Job Cuts Needed
Bloomberg
Thursday, May 8, 2014 - 10:42am
tags:
Pfizer, AstraZeneca, layoffs, M&A
Cytomedix shutters R&D site after PhII failure
Fierce Biotech
Thursday, May 8, 2014 - 8:53am
tags:
Cytomedix, R&D
Teleflex plans layoffs, plant closures in response to 'cost pressures'
Mass Device
Thursday, May 8, 2014 - 8:51am
tags:
layoffs, Teleflex Medical, devices
Lundbeck to acquire Chelsea Therapeutics for up to $658 mln
Reuters
Thursday, May 8, 2014 - 8:33am
tags:
Lundbeck, Chelsea Therapeutics, M&A
Is Abbott Laboratories Headed for a Breakup?
Motley Fool
Thursday, May 8, 2014 - 8:32am
tags:
Abbott Labs, M&A, generics, Mylan Labs, Teva Pharmaceuticals
FDA approves GW drug trial
Yahoo/Investors Business Daily
Thursday, May 8, 2014 - 8:31am
tags:
FDA, GW Pharma, Epidiolex
Cytokinetics Still Has Value, Despite Setbacks
Seeking Alpha
Thursday, May 8, 2014 - 8:28am
tags:
Cytokinetics, Omecamtiv Mecarbil, Tirasemtiv
Allergan Reports Strong Q1 While Weighing Valeant Bid
Investors.com
Wednesday, May 7, 2014 - 6:37pm
tags:
Allergan, earnings, Valeant Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.